Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -55.36% is in line with its 5-year average of -53.84%, around the middle of its 5-year range (-96.84%–-32.87%).
As of the fiscal period ended Tuesday, June 30, 2026. 18.54% above its 12-month average of -67.96%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -55.36%.
RETURN ON EQUITY (ROE)
-55.36%
RETURN ON EQUITY (ROE) AVG TTM
-67.96%
RETURN ON EQUITY (ROE) AVG 3Y
-63.32%
RETURN ON EQUITY (ROE) AVG 5Y
-53.84%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+18.54%
CURRENT VS 3Y AVG
+12.56%
CURRENT VS 5Y AVG
-2.82%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-31.79%
vs the sector median at left
Solid Biosciences Inc.
Market Cap
$681.27M
Return on Equity (ROE)
-55.36%
TTM Avg
-67.96%
3Y Avg
-63.32%
5Y Avg
-53.84%
Market Cap
$681.02M
Return on Equity (ROE)
-405.51%
TTM Avg
42.95%
3Y Avg
-55.53%
5Y Avg
-60.37%
Market Cap
$685.49M
Return on Equity (ROE)
-41.20%
TTM Avg
50554.28%
3Y Avg
25132.94%
5Y Avg
16622.35%
Market Cap
$673.41M
Return on Equity (ROE)
2.89%
TTM Avg
20.45%
3Y Avg
11.91%
5Y Avg
-3.26%
Market Cap
$691.79M
Return on Equity (ROE)
-47.51%
TTM Avg
-32.80%
3Y Avg
-39.18%
5Y Avg
-31.37%
Market Cap
$693.19M
Return on Equity (ROE)
-113.05%
TTM Avg
-95.98%
3Y Avg
-72.88%
5Y Avg
-73.85%
Market Cap
$693.61M
Return on Equity (ROE)
-44.64%
TTM Avg
-42.57%
3Y Avg
32.15%
5Y Avg
-68.82%
Market Cap
$694.79M
Return on Equity (ROE)
-25.03%
TTM Avg
-10.49%
3Y Avg
-5.87%
5Y Avg
-23.97%
Market Cap
$666.95M
Return on Equity (ROE)
-75.79%
TTM Avg
-55.51%
3Y Avg
-59.06%
5Y Avg
-60.41%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | $681.27M | -55.36% | -67.96% | -63.32% | -53.84% |
| Verastem, Inc. (VSTM)vs › | $681.02M | -405.51% | 42.95% | -55.53% | -60.37% |
| Anteris Technologies Global Corp. (AVR)vs › | $685.49M | -41.20% | 50554.28% | 25132.94% | 16622.35% |
| MiMedx Group, Inc. (MDXG)vs › | $673.41M | 2.89% | 20.45% | 11.91% | -3.26% |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $691.79M | -47.51% | -32.80% | -39.18% | -31.37% |
| Faeth Therapeutics, Inc. (FTH)vs › | $693.19M | -113.05% | -95.98% | -72.88% | -73.85% |
| Wave Life Sciences Ltd. (WVE)vs › | $693.61M | -44.64% | -42.57% | 32.15% | -68.82% |
| Cytek Biosciences, Inc. (CTKB)vs › | $694.79M | -25.03% | -10.49% | -5.87% | -23.97% |
| Helus Pharma Inc. (HELP)vs › | $666.95M | -75.79% | -55.51% | -59.06% | -60.41% |
| Annexon, Inc. (ANNX)vs › | $660.29M | -108.93% | -72.41% | -64.95% | -55.74% |
ROE
-55.4%
ROA
-49.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -55.36% |
| 2026-03-31 | -51.26% |
| 2025-12-31 | -96.84% |
| 2025-09-30 | -76.69% |
| 2025-06-30 | -59.66% |
| 2025-03-31 | -47.43% |
| 2024-12-31 | -90.86% |
| 2024-09-30 | -61.33% |
| 2024-06-30 | -46.93% |
| 2024-03-31 | -42.83% |
| 2023-12-31 | -75.91% |
| 2023-09-30 | -62.92% |
| 2023-06-30 | -55.13% |
| 2023-03-31 | -49.36% |
| 2022-12-31 | -40.62% |
| 2022-09-30 | -62.43% |
| 2022-06-30 | -53.63% |
| 2022-03-31 | -43.46% |
| 2021-12-31 | -34.67% |
| 2021-09-30 | -33.55% |
| 2021-06-30 | -32.87% |
| 2021-03-31 | -31.03% |
| 2020-12-31 | -66.84% |
| 2020-09-30 | -444.37% |
| 2020-06-30 | -262.32% |
| 2020-03-31 | -202.52% |
| 2019-12-31 | -146.44% |
| 2019-09-30 | -98.86% |
| 2019-06-30 | -126.87% |
| 2019-03-31 | -89.30% |
| 2018-12-31 | -59.75% |
| 2018-09-30 | -46.43% |
| 2018-06-30 | -38.11% |
| 2018-03-31 | -30.84% |
| 2017-09-30 | -192.37% |
